BE864917A - Ethers aminoalcoyliques de pyridinyle, procedes pour leur preparation et preparations pharmaceutiques les contenant - Google Patents

Ethers aminoalcoyliques de pyridinyle, procedes pour leur preparation et preparations pharmaceutiques les contenant

Info

Publication number
BE864917A
BE864917A BE185950A BE185950A BE864917A BE 864917 A BE864917 A BE 864917A BE 185950 A BE185950 A BE 185950A BE 185950 A BE185950 A BE 185950A BE 864917 A BE864917 A BE 864917A
Authority
BE
Belgium
Prior art keywords
aminoalcoyl
pyridinyl
ethers
preparation
methods
Prior art date
Application number
BE185950A
Other languages
English (en)
French (fr)
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of BE864917A publication Critical patent/BE864917A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
    • A61C8/00—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools
    • A61C8/0018—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools characterised by the shape
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
    • A61C2204/00—Features not otherwise provided for
    • A61C2204/002—Features not otherwise provided for using batteries

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dentistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
BE185950A 1977-03-17 1978-03-15 Ethers aminoalcoyliques de pyridinyle, procedes pour leur preparation et preparations pharmaceutiques les contenant BE864917A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19772711655 DE2711655A1 (de) 1977-03-17 1977-03-17 Pyridinyl-aminoalkylaether

Publications (1)

Publication Number Publication Date
BE864917A true BE864917A (fr) 1978-09-15

Family

ID=6003884

Family Applications (1)

Application Number Title Priority Date Filing Date
BE185950A BE864917A (fr) 1977-03-17 1978-03-15 Ethers aminoalcoyliques de pyridinyle, procedes pour leur preparation et preparations pharmaceutiques les contenant

Country Status (27)

Country Link
US (1) US4206117A (xx)
JP (1) JPS53116382A (xx)
AT (2) AT364360B (xx)
AU (1) AU525566B2 (xx)
BE (1) BE864917A (xx)
CA (1) CA1108148A (xx)
CH (1) CH638186A5 (xx)
CS (2) CS202011B2 (xx)
DD (1) DD134090A5 (xx)
DE (1) DE2711655A1 (xx)
DK (1) DK118578A (xx)
ES (1) ES467931A1 (xx)
FI (1) FI74962C (xx)
FR (1) FR2383930A1 (xx)
GB (1) GB1599061A (xx)
GR (1) GR64096B (xx)
HU (1) HU177287B (xx)
IE (1) IE46484B1 (xx)
IL (1) IL54265A0 (xx)
IT (1) IT1093796B (xx)
LU (1) LU79235A1 (xx)
NL (1) NL189563C (xx)
NO (1) NO150605C (xx)
SE (1) SE446185B (xx)
SU (2) SU799658A3 (xx)
YU (2) YU63678A (xx)
ZA (1) ZA781552B (xx)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0040591A1 (fr) * 1980-05-19 1981-11-25 S.A. Sanofi - Labaz N.V. Dérivés de pyridoxine, leur procédé de préparation ainsi que leur utilisation en thérapeutique

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4474781A (en) * 1979-04-02 1984-10-02 Merck & Co., Inc. Treating hypertension with aminoalkoxypyridines
DE3008522A1 (de) * 1980-03-06 1981-09-17 Basf Ag, 6700 Ludwigshafen 4-(alpha)-cycloamino-arylmethyl-6-methyl-1,3-dihydro-furo (3,4-c) -pyridin-7-ole, ihre herstellung und verwendung
JPS588066A (ja) * 1981-07-03 1983-01-18 Otsuka Pharmaceut Co Ltd 光学活性〔ｓ〕−（−）−カルボスチリル誘導体の製造法
DE3373466D1 (de) * 1982-06-10 1987-10-15 Beecham Wuelfing Gmbh & Co Kg Amine derivatives
DE3519693A1 (de) * 1985-06-01 1987-01-02 Basf Ag Pyridin-derivate, ihre herstellung und verwendung
GB8603475D0 (en) * 1986-02-12 1986-03-19 Glaxo Group Ltd Chemical compounds
GB8703007D0 (en) * 1987-02-10 1987-03-18 Glaxo Group Ltd Chemical compounds
GB9012926D0 (en) * 1990-06-09 1990-08-01 Scras Pyrrolo-pyridine derivatives
EP0934937B1 (en) * 1990-11-30 2002-02-27 Otsuka Pharmaceutical Co., Ltd. Azole derivatives as superoxide radical inhibitor
MY128323A (en) 1996-09-30 2007-01-31 Otsuka Pharma Co Ltd Thiazole derivatives for inhibition of cytokine production and of cell adhesion
US20010034357A1 (en) * 2000-02-02 2001-10-25 Nan-Horng Lin Substituted pyridine compounds useful for controlling chemical synaptic transmission
US20070208026A1 (en) * 2003-04-07 2007-09-06 Liu Kevin N-Containing Heteroaromatic Compounds As Modulators Of Ppars And Methods Of Treating Metabolic Disorders
SI2356109T1 (sl) 2008-10-10 2017-04-26 Vm Discovery, Inc. Sestavki in postopki za zdravljenje motenj zaradi uživanja alkohola, bolečine in drugih bolezni
KR101698153B1 (ko) * 2010-04-26 2017-01-23 광주과학기술원 Ｐ2ｘ1 및 ｐ2ｘ3 수용체 길항제로 사용되는 신규한 피리딘 카르복실산계 화합물, 이의 제조방법 및 이를 포함하는 조성물

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1572768A (en) * 1925-06-26 1926-02-09 Winthrop Chem Co Inc Pharmaceutical product
US1881236A (en) * 1929-08-10 1932-10-04 Soc Of Chemical Ind Basic ethers of the pyridine series
US3535328A (en) * 1967-09-01 1970-10-20 Exxon Research Engineering Co Certain substituted aminothioethoxy pyridines
US4115575A (en) * 1973-02-20 1978-09-19 Ciba-Geigy Corporation 2-(3-Amino-2-hydroxy-propoxy)-pyrazines
AR208397A1 (es) * 1973-02-20 1976-12-27 Ciba Geigy Ag Procedimiento para la elaboracion de compuestos de 1-piridiloxi-2-hidroxi-3-amino-propano1-piraziniloxi-2-hidroxi-3-amino-propano y 1-pirimidiniloxi-2-hidroxi-3-amino-propan
US4073909A (en) * 1973-10-08 1978-02-14 Sandoz Ltd. Isoquinoline compounds
CH591448A5 (xx) * 1974-05-14 1977-09-15 Ciba Geigy Ag
CH614711A5 (xx) * 1975-04-08 1979-12-14 Sandoz Ag
GB1504424A (en) * 1975-08-09 1978-03-22 Beecham Group Ltd Isoquinoline-derived aminoethers
GB1485919A (en) * 1975-08-12 1977-09-14 Grindstedvaerket As Pyridine derivatives
US4060601A (en) * 1976-06-15 1977-11-29 Merck & Co., Inc. Certain lower-alkyl amino-2'-hydroxy-propoxy pyridines

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0040591A1 (fr) * 1980-05-19 1981-11-25 S.A. Sanofi - Labaz N.V. Dérivés de pyridoxine, leur procédé de préparation ainsi que leur utilisation en thérapeutique
US4374841A (en) * 1980-05-19 1983-02-22 S. A. Labaz N.V. Pyridoxine derivatives, and use in therapeutics

Also Published As

Publication number Publication date
DE2711655A1 (de) 1978-09-21
IE780503L (en) 1978-09-17
IT7821099A0 (it) 1978-03-10
AU525566B2 (en) 1982-11-11
FI74962B (fi) 1987-12-31
GB1599061A (en) 1981-09-30
DD134090A5 (de) 1979-02-07
ES467931A1 (es) 1979-07-01
DK118578A (da) 1978-09-18
CA1108148A (en) 1981-09-01
AU3419578A (en) 1979-09-20
JPS6123790B2 (xx) 1986-06-07
NL189563B (nl) 1992-12-16
NL189563C (nl) 1993-05-17
SE7802927L (sv) 1978-09-18
IL54265A0 (en) 1978-06-15
FR2383930B1 (xx) 1982-10-22
DE2711655C2 (xx) 1987-07-16
NL7802719A (nl) 1978-09-19
ZA781552B (en) 1979-04-25
CS202011B2 (en) 1980-12-31
NO780931L (no) 1978-09-19
CH638186A5 (de) 1983-09-15
HU177287B (en) 1981-09-28
LU79235A1 (de) 1978-06-28
YU225282A (en) 1983-02-28
AT364361B (de) 1981-10-12
GR64096B (en) 1980-01-22
SU799658A3 (ru) 1981-01-23
US4206117A (en) 1980-06-03
SE446185B (sv) 1986-08-18
ATA187878A (de) 1981-03-15
NO150605B (no) 1984-08-06
YU63678A (en) 1983-01-21
NO150605C (no) 1984-11-14
SU850002A3 (ru) 1981-07-23
CS202012B2 (en) 1980-12-31
JPS53116382A (en) 1978-10-11
YU41016B (en) 1986-10-31
IE46484B1 (en) 1983-06-29
FR2383930A1 (fr) 1978-10-13
FI74962C (fi) 1988-04-11
IT1093796B (it) 1985-07-26
AT364360B (de) 1981-10-12
ATA84080A (de) 1981-03-15
FI780842A (fi) 1978-09-18

Similar Documents

Publication Publication Date Title
FR2445319B1 (fr) Derives de pyridine, procedes pour leur preparation et compositions pharmaceutiques les contenant
MA19048A1 (fr) Imidazo [1,2-a] pyridine,procedes pour leur preparation et composition pharmaceutiques les contenant .
FR2471968B1 (fr) Ethers basiques, leur procede de preparation et compositions pharmaceutiques les contenant
BE896986A (fr) Derives d'indole, procedes pour leur preparation et composition pharmaceutiques les contenant
MC1390A1 (fr) Derives de pyrazolopyridazine,procede pour leur preparation et compositions pharmaceutiques les contenant
BE859415A (fr) Nouveaux 1-aryloxy-2-hydroxy-3-alcoyleneaminopropanes procedes pour leur preparation et medicaments les renfermant
BE864917A (fr) Ethers aminoalcoyliques de pyridinyle, procedes pour leur preparation et preparations pharmaceutiques les contenant
BE893378A (fr) Derives de carboximide, procedes pour leur preparation et medicament les contenant
BE865851A (fr) Dipyrido(4,3-b) (3,4-f) indoles, procede d'obtention, application therapeutique et compositions pharmaceutiques les contenant
BE853422A (fr) Trans-hexahydro-pyrido-indoles, leur preparation et compositions pharmaceutiques les contenant
EP0005231A3 (en) Isoquinoline derivatives, process for their preparation and pharmaceutical preparations containing them
LU80436A1 (fr) Nouveaux derives du tetrazole,procedes pour leur preparation et compositions pharmaceutiques les contenant
MC1243A1 (fr) Derives peptidiques,procede pour leur preparation et leur application dans des preparations pharmaceutiques
BE866351A (fr) Nouveaux n- (1-(3-benzoylpropyl)-4-piperidyl) -sulfamides, procedes pour leur preparation et medicaments les renfermant
FR2537584B1 (fr) Pyrazoloquinoleines substituees particulieres, procede pour leur preparation, preparations pharmaceutiques contenant ces composes et leur application therapeutique
FR2485537B2 (fr) Dipyrido(4,3-b)(3,4-f)indoles, procede d'obtention, application therapeutique et compositions pharmaceutiques les contenant
BE885156A (fr) Psoralenes, leur procede de preparation et compositions pharmaceutiques les contenant
BE867638A (fr) Nouvelles 5,11-dihydro-6h-pyrido (2,3-b) (1,4) benzodiazepin-6-ones, procedes pour leur preparation et medicaments renfermant ces composes
BE885507A (fr) Composes heterocycliques, procedes pour leur preparation et compositions pharmaceutiques les contenant
BE871857A (fr) Nouvelles piperazines disubstituees, leur procedes de preparation et les compositions pharmaceutiques les renfermant
DE2860111D1 (en) New bispidine derivatives, process for their preparation and medicinal preparations containing them
BE884101A (fr) Derives d'isoquinoleine contenant du soufre, procedes pour leur preparation et composition pharmaceutiques les contenant
DE2960675D1 (en) Isoquinolines, process for their preparation, and pharmaceutical preparations containing them
BE889497A (fr) Aminocyclopentanone amides, leur preparation et compositions pharmaceutiques qui les contiennent
FR2340310A1 (fr) Hydrazinophtalazines substituees, leur preparation et compositions pharmaceutiques les contenant

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: BASF A.G.

Effective date: 19930331